Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04289779
Title Study of CAbozantinib in Combination With AtezolizumaB for Muscle-Invasive BladdEr Cancer (ABATE) (ABATE)
Acronym ABATE
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Deepak Kilari
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.